Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
Titel:
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
Auteur:
Gao, Xiangyu Xu, Nong Li, Ziyu Shen, Lin Ji, Ke Zheng, Zhong Liu, Dan Lou, Hanmei Bai, Li Liu, Tianshu Li, Yunxia Li, Yuzhi Fan, Qingxia Feng, Mei Zhong, Haijun Huang, Yi Lou, Ge Wang, Jing Lin, Xiaoyan Chen, Ye An, Ruifang Li, Changzheng Zhou, Qi Huang, Xin Guo, Zengqing Wang, Shubin Li, Guiling Fei, Junwei Zhu, Lijing Zhu, Hong Li, Xiumin Li, Fenghu Liao, Sihai Min, Qinghua Tang, Lei Shan, Fei Gong, Jifang Gao, Yunong Zhou, Jun Lu, Zhihao Li, Xiaofan Li, Jianjie Ren, Hui Liu, Xiaohong Yang, Hongxia Li, Wenting Song, Weifeng Wang, Zhongmin Maxwell Li, Baiyong Xia, Michelle Wu, Xiaohua Ji, Jiafu